These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 13734715)

  • 1. [A new medication of myasthenia and neuromuscular dystrophies: nivaline].
    PESTEL M
    Presse Med (1893); 1961 Jan; 69():182-3. PubMed ID: 13734715
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dietary therapy of Erb's progressive muscular dystrophy and myasthenia gravis pseudoparalytica].
    EVERS J
    Dtsch Z Nervenheilkd; 1955; 173(5-6):536-7. PubMed ID: 13305351
    [No Abstract]   [Full Text] [Related]  

  • 3. Perspectives on the treatment of neuromuscular disease.
    Griggs RC
    Adv Neurol; 1977; 17():1-12. PubMed ID: 196498
    [No Abstract]   [Full Text] [Related]  

  • 4. [Muscular diseases].
    Refsum S
    Tidsskr Nor Laegeforen; 1971 Apr; 91(11):838-40. PubMed ID: 5089806
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of myasthenia gravis.
    Saperstein DS; Barohn RJ
    Semin Neurol; 2004 Mar; 24(1):41-8. PubMed ID: 15229791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Physical therapy in patients with myopathies].
    Rulffs W
    Munch Med Wochenschr; 1969 Mar; 111(11):578-91. PubMed ID: 5819340
    [No Abstract]   [Full Text] [Related]  

  • 7. Juvenile limb-girdle myasthenia gravis.
    Rodolico C; Pastura C; Sinicropi S; Girlanda P; Toscano A; Messina C; Vita G
    Neuropediatrics; 2005 Dec; 36(6):353-6. PubMed ID: 16429374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical results and considerations on a new anticholinesterase agent (Nivaline) in the treatment of postoperative ileus].
    FERRARA L; VIDILI F; ALETTI L
    Minerva Anestesiol; 1961 Feb; 27():74-8. PubMed ID: 13699039
    [No Abstract]   [Full Text] [Related]  

  • 9. [The use of galantamine bromhydrate (nivaline) in the paralytic sequelae of poliomyelitis, neuraxitis and in muscular dystrophy].
    LOMBARDO G; ARENA G
    Minerva Pediatr; 1962 Jun; 14():724-8. PubMed ID: 14466410
    [No Abstract]   [Full Text] [Related]  

  • 10. Cholinergic crises in the treatment of myasthenia gravis.
    SKINHOJ E; PETERSEN H
    Dan Med Bull; 1957 Jul; 4(4):126-7. PubMed ID: 13461495
    [No Abstract]   [Full Text] [Related]  

  • 11. Myasthenia gravis.
    Khadilkar SV; Sahni AO; Patil SG
    J Assoc Physicians India; 2004 Nov; 52():897-904. PubMed ID: 15906843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic options in autoimmune myasthenia gravis.
    García-Carrasco M; Escárcega RO; Fuentes-Alexandro S; Riebeling C; Cervera R
    Autoimmun Rev; 2007 Jun; 6(6):373-8. PubMed ID: 17537383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symposium on care of the patient with neuromuscular disease.
    Nurs Clin North Am; 1979 Mar; 14(1):93-190. PubMed ID: 256024
    [No Abstract]   [Full Text] [Related]  

  • 14. Myasthenia gravis.
    Kothari MJ
    J Am Osteopath Assoc; 2004 Sep; 104(9):377-84. PubMed ID: 15452103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymoma, myasthenia gravis, and other paraneoplastic syndromes.
    Tormoehlen LM; Pascuzzi RM
    Hematol Oncol Clin North Am; 2008 Jun; 22(3):509-26. PubMed ID: 18514130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of myasthenia gravis.
    Schwendimann RN; Burton E; Minagar A
    Am J Ther; 2005; 12(3):262-8. PubMed ID: 15891271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular myasthenia gravis.
    Gilbert ME; Savino PJ
    Int Ophthalmol Clin; 2007; 47(4):93-103, ix. PubMed ID: 18049283
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy in child neurology].
    Göllnitz G
    Psychiatr Neurol Med Psychol Beih; 1966; 4-5():262-80. PubMed ID: 4378040
    [No Abstract]   [Full Text] [Related]  

  • 19. [Juvenile-onset muscular diseases].
    Aden P; Annexstad EJ; Lien E; Tajsic JM; Mjellem N; Rasmussen M
    Tidsskr Nor Laegeforen; 2017 Jan; 137(2):108-111. PubMed ID: 28127073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myasthenia gravis: clinical, immunological, and therapeutic advances.
    Romi F; Gilhus NE; Aarli JA
    Acta Neurol Scand; 2005 Feb; 111(2):134-41. PubMed ID: 15644074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.